iShares Dow Jones US Medical Dev. Stock Price, News & Analysis (BMV:IHI)

iShares Dow Jones US Medical Dev. trades on the BMV under the ticker symbol "IHI."

iShares Dow Jones US Medical Dev. declared a -- dividend on Tuesday, September 24th. Investors of record on Wednesday, September 25th will be paid a dividend of $0.1886 per share on Monday, September 30th. This represents a yield of 0.3%. The ex-dividend date is Tuesday, September 24th. View iShares Dow Jones US Medical Dev.'s Dividend History.

News coverage about IHI stock has been trending somewhat positive on Monday, InfoTrie Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. iShares Dow Jones US Medical Dev. earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for iShares Dow Jones US Medical Dev..

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Dow Jones US Medical Dev. investors own include Shopify (SHOP), Adobe (ADBE), Cyberark Software (CYBR), iShares 20+ Year Treasury Bond ETF (TLT), salesforce.com (CRM), Veeva Systems (VEEV), Booking (BKNG), Coupa Software (COUP), IQIYI (IQ) and Micron Technology (MU).

Shares of IHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.